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The mechanical compression theory explaining the origin of glaucoma considers elevated 
intraocular pressure as the most important risk factor for the disease. This theory gives 
support to the essential signs of glaucomatous optic neuropathy, such as increased cupping 
and neuroretinal rim thinning but does not explain the existence of normal tension 
glaucoma. Alternatively, the vascular ischemia theory supposes that vascular insufficiency 
in the optic nerve head results in decreased metabolic activity, which subsequently leads to 
increased glutamate accumulation and ganglion cell death. Indeed, a large number of 
studies have shown a high association between glaucomatous optic neuropathy and 
vascular disorders related to hypertension, diabetes and hypercholesterolemia. 
Oxidative stress has been implicated to cause increased intraocular pressure by triggering 
trabecular meshwork degeneration and thus contributing to alterations in the aqueous 
outflow pathway. It has also been demonstrated that oxidative DNA damage is significantly 
greater in trabecular meshwork cells of glaucoma patients compared with controls. 
Moreover, in vivo studies in humans have shown that both intraocular pressure increase and 
visual field damage are significantly related to the amount of oxidative DNA damage. 
Similarly, severity of optic nerve damage in eyes with primary open angle glaucoma is 
correlated with changes in the trabecular meshwork. Retinal oxidative injury occurring in 
models of elevated intraocular pressure or in normal tension glaucoma also directly damage 
the retinal ganglion cell layer, leading to glaucomatous optic neuropathy. Free radical injury 
has been reported to cause caspase independent cell death in retinal ganglion cells in vitro. 
Furthermore, many retinal proteins exhibit oxidative modifications in experimental 
glaucoma, which may lead to important structural and functional alterations.  
Ocular tissues and fluids contain antioxidants that play a key role in protecting against 
oxidative damage. However, specific activity of a major antioxidant enzyme, superoxide 
dismutase, demonstrates an age-dependent decline in normal human trabecular meshwork. 
Similarly, plasma glutathione levels assessed in patients with newly diagnosed primary 
open angle glaucoma and age- and gender-matched control subjects revealed that glaucoma 
patients exhibited significantly lower levels of reduced and total glutathione than did 
control subjects.  
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Recent studies have also highlighted the role of nitric oxide in glaucoma by reporting the 
presence of inducible nitric oxide synthase in the iris-ciliary body, retina and in the 
glaucomatous optic nerve head of experimental rat models. This chapter will discuss the 
role of reactive oxygen and nitrogen species in the pathogenesis of glaucoma and examine 
the relevance of antioxidants in neurodegeneration associated with the disease. 
Pathophysiological mechanisms leading to glaucomatous optic neuropathy remain 
uncertain. Mechanical compression and vascular ischemia have been suggested to play a 
leading role in the observed neuronal damage (Fechtner & Weinreb, 1994). The mechanical 
compression theory considers elevated intraocular pressure as the most important risk 
factor for the disease (Yan et al., 1994). The mechanism of elevated intraocular pressure in 
glaucoma is impaired outflow of aqueous humour resulting from abnormalities within the 
drainage system of the anterior chamber angle (open-angle glaucoma) or impaired access of 
aqueous humour to the drainage system (angle-closure glaucoma) (Salmon et al., 2008). 
Aqueous humour produced by the ciliary body enters the posterior chamber, passes 
through the pupil into the anterior chamber and then to the trabecular meshwork in the 
anterior chamber angle. Trabecular meshwork drains the aqueous fluid into the canal of 
Schlemm (Figure 1) and is composed of beams of collagen and elastic tissue covered by 
trabecular cells (Salmon et al., 2008). Trabecular cells are endothelial-like cells that have 
capacities of phagocytosis, and the ability to produce matrix-degrading enzymes, 
extracellular matrix elements and transforming growth factor-ǃ (Tripathi et al., 1994; Yun et 
al., 1989).  
 
 
Fig. 1. Anterior segment structures and formation of aqueous humour  
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Oxidative stress has been implicated to cause increased intraocular pressure by triggering 
trabecular meshwork degeneration and thus contributing to alterations in the aqueous 
outflow pathway (Sacca et al., 2007). Indeed, treatment with hydrogen peroxide (H2O2) 
impairs trabecular meshwork cell adhesion to the extracellular matrix and causes 
rearrangement of cytoskeletal structures (Zhou et al., 1999). It has also been demonstrated 
that oxidative DNA damage is significantly greater in trabecular meshwork cells of 
glaucoma patients compared with controls (Izzotti et al., 2003). Moreover, in vivo studies in 
humans have shown that both intraocular pressure increase and visual field damage are 
significantly related to the amount of oxidative DNA damage (Sacca et al., 2005). Similarly, 
severity of optic nerve damage in eyes with primary open-angle glaucoma is correlated with 
changes in the trabecular meshwork (Gottanka et al., 1997). 
MicroRNA (miRNA) are an abundant class of noncoding small (~22 nucleotides) RNAs that 
modulate gene expression at the post-transcriptional level and participate in the regulation 
of many cellular functions (Wu et al, 2006; Filipowicz et al., 2008; Stefani et al., 2008) 
Specifically, miR-29b has been demonstrated to regulate multiple genes coding for 
extracellular matrix proteins, including multiple collagens, fibrillins, and elastin (Luna et al., 
2009b). The role of microRNA (miRNA) in the trabecular meshwork and the potential 
involvement on the alterations in extracellular matrix synthesis induced by oxidative stress 
was studied in human trabecular meshwork cell cultures, which were generated from 
cadaver eyes with no history of eye disease within 48 h post mortem. These cells were 
transfected with miR-29b mimic. Chronic oxidative stress was induced by incubation at 40% 
oxygen for 4–5 days. Control human trabecular meshwork cell cultures were incubated at 
5% oxygen. Transfection of human trabecular meshwork cells with miR-29b mimic resulted 
in downregulation of multiple extracellular matrix components. Chronic oxidative stress 
induced a significant downregulation of miR-29b in human trabecular meshwork cell lines 
and increased expression of several extracellular matrix genes known to be regulated by 
miR-29b. The increase in expression of these genes was inhibited by transfection with miR-
29b mimic. MiR-29b increased cell viability under both chronic oxidative stress and 
physiologic oxygen concentrations. These data suggest that miR-29b negatively regulates 
the expression of multiple genes involved in the synthesis and deposition of extracellular 
matrix in trabecular meshwork cells. Downregulation of miR-29b might contribute to 
increased expression of several extracellular matrix genes under chronic oxidative stress 
conditions. The balance between the activation of extracellular matrix production induced 
by oxidative stress and the protective effects of miR-29b could be a relevant factor in 
understanding how oxidative damage may lead to increased deposition of extracellular 
matrix in the trabecular meshwork and contribute to the elevation of intraocular pressure 
via obstruction of the trabeculum by deposition of an extracellular matrix (Luna et al., 
2009b). 
Oxidative destruction of cellular components usually accompanies ocular tissue injury in 
animal models of elevated intraocular pressure. Markers of oxidative stress such as protein 
carbonyl formation and lipid peroxidation products have been documented in experimental 
models of ocular hypertension. Glyceraldehyde-3-phosphate dehydrogenase, heat shock 
protein 72 and glutamine synthetase show a significant increase in the relative percentage of 
carbonyl immunoreactivity in chronic pressure induced rat models of glaucoma as 
compared with controls (Tezel et al., 2005) Likewise, increased retina lipid oxidation is 
detected in rats with elevated intraocular pressure (Ko et al., 2005).  
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Circadian fluctuation of mean ocular perfusion pressure is a consistent risk factor for disease 
progression in normal-tension glaucoma (Choi et al., 2007). It is hypothesized that unstable 
ocular blood flow in patients with normal intraocular pressure can lead to reperfusion 
injury and result in oxidative stress (Mozaffarieh et al., 2008b). Peripheral vascular 
insufficiency, accompanied by restoration of blood flow, places organs at risk of additional 
injury by inducing a proinflammatory state reflected by enhanced superoxide (O2—)and 
hydrogen peroxide (H2O2) generation (Henry et al., 1990). These reactive species are usually 
derived from autoxidation of mitochondrial respiratory chain components (Wallace, 1999), 
which are also found to be present within the retinal ganglion cells, nerve fiber layer, outer 
plexiform layer, inner segments of photoreceptors, and the retinal pigment epithelium 
(Andrews et al., 1999). 
A recent study has showed that mice deficient in the glutamate transporters GLAST or 
EAAC1 demonstrate spontaneous retinal ganglion and optic nerve degeneration without 
elevated intraocular pressure. In GLAST deficient mice, the glutathione level in Müller glia 
was found to be decreased and it was concluded that glutamate transporters are necessary 
both to prevent excitotoxic retinal damage and to synthesize glutathione, a major cellular 
antioxidant (Harada et al., 2007). 
Reported findings also suggest a role for oxidative stress in the pathogenesis and 
progression of pseudoexfoliation glaucoma. Pseudoexfoliation syndrome is characterized by 
production and progressive accumulation of fibrillar extracellular material in many ocular 
tissues, most commonly seen on the pupillary border and anterior lens capsule (Ritch & 
Schlotzer-Schrehardt, 2001). Accumulation of the exfoliation material or pigment particles in 
the angle can predispose to both open angle and angle-closure glaucoma (Ritch et al., 2003). 
The pathogenesis and etiology underlying the development of Pseudoexfoliation syndrome 
and the subsequent progression from Pseudoexfoliation syndrome to glaucoma remain 
unclear. 
In summary, this review discusses the role of retinal oxidative and nitrative injury in the 
pathogenesis of glaucomatous neurodegeneration and examines the relevance of 
antioxidants in altering and/or inhibiting neuronal degeneration associated with the disease 
2. Reactive oxygen and nitrogen species 
2.1 Sources of superoxide and reactive oxygen species 
The generation of reactive oxygen species is associated with life under aerobic conditions 
and reactive intermediates are produced under both physiological and pathophysiological 
conditions (Freeman & Crapo, 1982). Reactive oxygen species are capable of damaging 
biological macromolecules such as DNA, carbohydrates or proteins. These oxygen 
metabolites are either radicals, e.g. hydroxyl radical (OH), peroxyl radical (ROO), or 
reactive non-radical compounds such as singlet oxygen, peroxynitrite (ONOO—) or 
hydrogen peroxide (H2O2) (Bergamini et al., 2004). As explained in more detail below, 
sources of reactive oxygen species in the eye are sunlight, mitochondria respiration, and 
cellular metabolic reactions. 
Superoxide (O2—) is the primary free radical formed within the cell by the reduction of 
molecular oxygen (Freeman & Crapo, 1982). The superoxide radical anion (O2—) appears to 
play a central role as other reactive intermediates are formed from it. The respiratory chain 
in mitochondria is a powerful source of reactive oxygen species, primarily superoxide  
(O2—) and consequently hydrogen peroxide (H2O2), as a product of superoxide (O2—) 
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dismutation (Chance et al., 1979) figure 2. This is due to the probable ‘leak' of single electron 
at the specific site of the mitochondrial electron transport chain, resulting in inappropriate 
single electron reduction of oxygen to superoxide (O2—) (Loschen et al., 1974.) Another 
significant source of reactive oxygen species is inflammatory reactions, especially chronic 
inflammation. Inflammatory cells such as activated macrophages and neutrophils release 
various reactive oxygen species (hydrogen peroxide [H2O2], nitric oxide [NO], superoxide 
[O2—]) and hypochlorite (HOCl) (Fantone & Ward, 1982). Neutrophils possess a membrane-
bound multicomponent enzyme complex termed the NADPH oxidase that, when activated, 
generates large quantities of reactive oxygen species (Babior et al., 2002). This system is 
responsible for the neutrophil “respiratory burst” (increased respiration of phagocytosis).  
The external environment can also generate reactive oxygen species from many sources 
including heat, UV light, therapeutic drugs, and χ- and Ǆ- radiation (Nikjoo et al., 1994). In 
an iron catalyzed Haber-weiss reaction, superoxide (O2—), ascorbate, thiols and other 
reductants reduce Fe3+ to Fe2+, which in turn reduces hydrogen peroxide (H2O2) to form the 
hydroxyl radical (OH), a potent oxidant that causes lipid oxidation (Freeman & Crapo, 
1982) figure 2. Mitochondria are also a major site for the accumulation of low molecular 
weight Fe2+ complexes, which promote the oxidative damage of membrane lipids, proteins, 
and mitochondrial DNA. 
 
 
Fig. 2. Formation of reactive oxygen radicals 
The hydroxyl radical (OH) is the most reactive oxygen species. Due to its high reactivity, 
this radical immediately reacts with surrounding target molecules at the site where it is 
generated. Peroxyl radicals can be generated in the process of lipid peroxidation, which is 
initiated by the abstraction of a hydrogen atom from polyunsaturated fatty acids (Spiteller, 
2006). Peroxyl radicals are relatively long-lived species with a considerable diffusion 
pathlength in biological systems. Further products generated in lipid peroxidation are 
aldehydes (Esterbauer et al., 1991). 
While lipid peroxidation is not initiated by superoxide (O2—) and hydrogen peroxide 
(H2O2), hydroxyl radical (OH), alkoxy radicals (RO), and peroxyl radical (ROO) result in 
the initiation of lipid peroxidation (Kanner et al., 1987) figure 2. Lipid peroxy radicals react 
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with other lipids, proteins, and nucleic acids propagating thereby the transfer of electrons 
and bringing about the oxidation of substrates. Cell membranes, which are structurally 
made up of large amounts of polyunsaturated fatty acids, are highly susceptible to oxidative 
attack and, consequent changes result in altered membrane fluidity, permeability, and 
cellular metabolic dysfunction (Spiteller, 2002). 
2.2 Sources of nitric oxide and reactive nitrogen species 
Nitric oxide (NO) is a free radical but is believed to be essentially a beneficial metabolite 
and indeed it may react with lipid peroxides and function as an antioxidant (Hogg et al., 
1993). Because nitric oxide (NO) is a free gas, it easily penetrates through biological 
membranes (Lancaster, 1997). Nitric oxide synthase (NOS) enzymatically generates nitric 
oxide (NO) by catalyzing the oxidation of the terminal guanidino nitrogen of L-arginine, 
converting the precursor amino acid substrate to L-citrulline (Alderton et al., 2001). Nitric 
oxide synthase isoforms generally fall into two categories: (i) constitutive nitric oxide 
synthases (NOS-I and NOS-III) that are dependent on Ca2+/calmodulin and (ii) inducible 
nitric oxide synthase (NOS-II or iNOS), the expression of which is increased by cytokines 
and other inflammatory stimuli. Inducible nitric oxide synthase binds Ca2+/calmodulin at 
all physiologic Ca2+ concentrations and unlike the other two isoforms is not subject to Ca2+-
dependent regulation (Daff, 2010). There are three nitric oxide synthase isoforms, neuronal 
(nNOS, NOS-I), inducible (iNOS, NOS-II), and endothelial (eNOS, NOS-III), all of which 
require NADPH and O2 as co-substrates. Nitric oxide synthases- I and nitric oxide 
synthases-III isoforms have been cloned from the human retina and retinal vascular 
endothelial cells, respectively (Park et al., 1994; Chakravarthy et al., 1995). Nitric oxide 
synthases-I has also been identified in amacrine cells, in the inner nuclear layer and in 
photoreceptors of the retina from different species by immunohistochemistry (Perez et al., 
1995). Nitric oxide synthases-II isoform has been documented in the cornea, iris, ciliary 
body, neural retina, retinal glial cells, retinal pigmented epithelial cells and optic nerve head 
under conditions of increased intraocular pressure and uveitis (Becquet et al., 1997; Aslan et 
al., 2007). 
2.3 Interaction between nitric oxide and oxygen radicals 
Superoxide radical (O2—) has a high affinity toward nitric oxide (NO). Reaction between 
nitric oxide (NO) and superoxide (O2—) produces a new molecule, which is called 
peroxynitrite (ONOO–) (Beckman et al., 1990). Peroxynitrite (ONOO–) is a highly reactive 
molecule and can cause extensive damage to proteins, lipids, and especially DNA 
molecules. The reaction of nitric oxide (NO) with metalloproteins, protein sulfhydryls and 
oxygen derived free radicals enables nitric oxide (NO) to modulate inflammation and 
oxidative stress (Rubbo et al., 1996). 
The conjugate acid of peroxynitrite (ONOO–), peroxynitrous acid (ONOOH), reacts by two 
pathways, with the first pathway yielding nitrate (NO3−) without forming strong oxidant 
intermediates. The second pathway forms hydroxyl radical (OH) and nitrogen dioxide 
(NO2), a potent oxidant that can initiate fatty acid oxidation and nitration of amino acids 
(Beckman et al., 1990). Peroxynitrite (ONOO–) reactivity is also influenced by CO2, with the 
formation of a reactive nitrosoperoxocarbonate (ONOOCO2-) intermediate. Consequently, 
CO2 stimulates both peroxynitrite (ONOO–) decay and enhances peroxynitrite (ONOO–)–
mediated nitration of molecules by nearly 2-fold (Radi et al., 1999) figure 3. 
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Oxidases and oxygenases, in particular, are critical sources of oxygen radical production 
and can lead to an overall impairment of nitric oxide (NO) signaling, via the metalloprotein 
and free radical–mediated consumption of this vasoactive molecule. Oxidase and oxygenase 
activities can thus account for the functional inactivation of nitric oxide (NO), leading to a 





















Fig. 3. Pathways of peroxynitrite formation and decay 
3. Apoptosis in glaucomatous neurodegeneration 
The major mechanism of visual loss in glaucoma is retinal ganglion cell apoptosis, leading to 
thinning of the inner nuclear and nerve fiber layers of the retina and axonal loss in the optic 
nerve (Fechtner & Weinreb, 1994). Atrophy occuring in neurons located at magno- and 
parvocellular layers in the lateral geniculate nucleus of the thalamus is also reported in 
experimental glaucoma (Yücel et al., 2001). The lateral geniculate nucleus is the primary 
relay center for visual information received from the retina of the eye. (Xu et al., 2001). It is 
reported that neurons in parvocellular layers undergo significantly more shrinkage than 
neurons in magnocellular layers (Yücel et al., 2001).  
In animal models of ocular hypertension, elevated intraocular pressure augments apoptosis 
in retinal cells, induces nitric oxide synthases-2 expression and leads to protein nitration 
(Aslan et al., 2006) suggesting that nitrative stress exacerbates disease progression in clinical 
conditions accompanied by ocular degeneration. Reported studies also demonstrate the 
presence of nitric oxide synthases-2 in glaucomatous optic nerve head with consistent 
staining of nitrotyrosine, indicating that reactive nitrogen species may contribute to retinal 
ganglion cell death associated with elevated intraocular pressure (Liu & Neufeld, 2000; 
Shareef et al., 1999). Indeed, pharmacological studies have shown that inhibition of nitric 
oxide synthases-2 by aminoguanidine provides neuroprotection to retinal ganglion cells in a 
rat model of chronic glaucoma (Neufeld et al., 1999). 
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Nitric oxide-mediated cytotoxicity and the capacity of nitric oxide (NO) to induce apoptosis 
have been documented in macrophages (Sarih et al., 1993) astrocytes (Hu & Van Eldik, 1996) 
and neuronal cells (Heneka et al., 1998). Reactive oxygen and nitrogen species are important 
regulators of apoptosis, which can be induced by two major pathways. The extrinsic 
pathway involves binding of TNF-ǂ and Fas ligand to membrane receptors leading to 
caspase-8 activation, while the intrinsic pathway participates in stress-induced mitochondrial 
cytochrome c release. Released cytochrome c makes a complex with apoptotic protease-
activating factor-1 (Apaf-1) and procaspase-9, which induces activation of caspase-9. Both 
pathways converge on caspase-3 activation, resulting in cellular morphological changes 
such as blebbing and nuclear degradation (Figure 4) (Reed, 2000).  
 
 
Fig. 4. Extrinsic and intrinsic pathways for apoptosis. The extrinsic pathway can be induced 
by members of the TNF family receptors such as TNFR and FAS. The intrinsic pathway can 
be activated by release of cytochrome c from mitochondria. In the cytosol, cytochrome c binds 
and activates Apaf-1, allowing it to bind and activate caspase-9. Caspase-9 and -8 activate 
caspase-3. Main signaling components of nitric oxide (NO)-initiated apoptotic cell death are 
presented in red. For details, see the text. Apaf-1, apoptotic protease-activating factor-1; Cyt c, 
cytochrome c; JNK, c-Jun N-terminal kinase; p38 MAPK, p38 mitogen-activated protein kinase 
Nitrative and oxidative stress induce apoptotic cell death by the activation of c-Jun N-
terminal kinase (JNK; also referred to as stress activated protein kinase or SAPK) and p38 
mitogen-activated protein (MAP) kinase leading to caspase 3 activation (Saeki et al., 2002; 
Jun et al., 1999) . Nitric oxide can also directly induce cytochrome c release from the 
mitochondria by tyrosine nitration of cytochrome c (Hortelano et al., 1999). High 
concentrations of nitric oxide (NO) and peroxynitrite (ONOO–) are reported to cause DNA 
damage and lead to p53-mediated growth arrest and apoptosis (Kim et al., 1999).  
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Nuclear factor-κB plays a protective role against apoptosis through the up-regulation of 
genes encoding anti-apoptotic proteins (Chen et al., 1999). Nitric oxide inhibits nuclear 
factor-κB activation, by inducing the expression of the nuclear factor-κB inhibitor, and 
stabilization of the nuclear factor-κB/nuclear factor-κB inhibitor complex (Peng et al., 1995). 
In contrast to nitric oxide (NO), oxidative stress activates nuclear factor-κB inhibitor kinase, 
which leads to the phosphorylation of nuclear factor-κB inhibitor and activation of nuclear 
factor-κB. The activation of nuclear factor-κB inhibitor kinase and phosphorylation of 
nuclear factor-κB inhibitor can be blocked by antioxidants and nitric oxide (NO) (Chen et 
al., 1999). With reference to reported studies one can predict that induction of apoptosis 
requires fine biochemical interplay between oxygen and nitrogen species. The main 
signaling components of nitric oxide (NO)-initiated apoptotic cell death are illustrated in 
figure 4.  
4. Oxidative stress and immune response regulation in glaucomatous 
neurodegeneration 
Oxidative stress is also linked to immunostimulatory signaling on the immunogenic aspects 
of glaucoma. The regulation of immune response can be in many different ways via 
oxidative stress in glaucoma (Tezel, 2010). One of these events is oxidative protein 
modifications as detected by proteomic analysis of the retina in experimental glaucoma 
(Tezel et al. 2005). Oxidation may change the antigenic features of these proteins, thereby 
serving as an immunostimulatory signal during glaucomatous neurodegeneration (Tezel, 
2010). In addition to increasing antigenity, oxidative modifications may also affect the 
neurosupportive and immunoregulatory functions of glial cells (Tezel, 2010). Oxidized 
proteins, lipids, and DNA become para-inflammatory stimuli and signal to resident immune 
cells, mainly including microglia, to initiate an innate immune response (Xu et al., 2009). 
With enhanced scavenger functions, microglial cells are able to remove oxidation products 
by phagocytosis and they may release growth factors and cytokines to promote tissue 
healing (Schwartz, 2003; Ransohoff & Perry, 2009). This is in the same notion proposed for 
regulatory T cells (Schwartz & Kipnis, 2002). However, if oxidative stress reaches to a certain 
level, the physiological homeostasis may be impaired, thereby evolving into an injury 
process. In this case, initial glial response expands and leads to increased production of pro-
inflammatory cytokines (Tezel, 2010). 
Complement activation constitutes another important component of the innate immune 
activities detected in glaucomatous neurodegeneration. The regulation of complement 
activation was studied in oxidative stress-mediated glaucoma. Human retinal protein 
samples obtained from donor eyes with or without glaucoma were analyzed by a 
quantitative proteomic approach using mass spectrometry. Tissue lysates were spiked with 
recombinant protein standards for spectral count normalization and digested with modified 
trypsin. Resulting peptides were loaded onto an analytical capillary chromatography 
column attached to an analytical reverse phase chromatography column. Ionized peptides 
were eluted into a linear ion trap mass spectrometer. Spectra were acquired and analyzed 
via tandem mass spectrometry. Cellular localization of protein expression for different 
complement components and regulators were also determined by immunohistochemical 
analysis of an additional group of human donor eyes with glaucoma compared with age-
matched control eyes without glaucoma. In addition, to determine the regulation of 
complement factor H by oxidative stress, in vitro experiments were performed using rat 
www.intechopen.com
  
Glaucoma - Basic and Clinical Concepts 
 
94 
retinal cell cultures incubated in the presence and absence of an oxidant treatment. 
Proteomic and immunohistochemical analysis identified an increase in complement 
components C1q and C3b and the membrane attack complex C5b-9. In addition, several 
complement regulatory proteins were detected in the human retinal proteome, and 
glaucomatous samples exhibited a trend toward downregulation of complement factor H 
expression. In vitro experiments revealed that oxidative stress, which was also prominently 
detectable in the glaucomatous human retinas, downregulated complement factor H 
expression in retinal cells. These findings expand the current knowledge of complement 
activation by presenting new evidence in human glaucoma and support that despite 
important roles in tissue cleaning and healing, a potential deficiency in intrinsic regulation 
of complement activation, as is evident in the presence of oxidative stress, may lead to 
uncontrolled complement attack with neurodestructive consequences (Tezel et al., 2010).  
Other consequences of oxidative stress facilitating an aberrant immune activity in glaucoma 
include the augmented generation of advanced glycation end products through oxidative 
stress-dependent processes (Tezel et al., 2007). Advanced glycation end products may act as 
persistent antigenic stimulus and also be immunostimulatory through a specific receptor for 
advanced glycation end products-mediated signaling that leads to pro-inflammatory 
cytokine production (Lin, 2006). Oxidative stress provides a common trigger for many 
downstream pathways compromising the perivascular barrier function (Pun et al., 2009) 
may similarly affect blood vessels in human glaucoma (Feilchenfeld et al., 2008). 
The regulation of immune response through glial toll-like receptor signaling was studied in 
glaoucumatous oxidative stress (Luo et al., 2010). Retinal protein samples obtained from 
human donor eyes were analyzed by a quantitative proteomic approach involving mass 
spectrometry. Cellular localization of toll-like receptor-2, -3, and -4 was also determined by 
immunohistochemical analysis of an additional group of human donor eyes with glaucoma 
and control eyes. In addition, in vitro experiments were performed in rat retinal microglia 
and astrocytes to determine glial toll-like receptor expression and immunoregulatory 
function after exposure to hydrogen peroxide (H2O2)-induced oxidative stress. Proteomic 
analyses of the human retina detected expression and differential regulation of different toll-
like receptors in glaucomatous samples. Immunohistochemical analysis supported 
upregulated expression of toll-like receptors on both microglia and astrocytes in the 
glaucomatous retina. In vitro experiments provided additional evidence that oxidative 
stress upregulate glial toll-like receptor and MHC class II expression and cytokine 
production through toll-like receptor signaling and stimulate proliferation and cytokine 
secretion of co-cultured T cells during antigen presentation. This study supports the 
upregulation of toll-like receptor signaling in human glaucoma, which may be associated 
with innate and adaptive immune responses. In vitro findings showed that oxidative stress-
mediated glaucomatous tissue stress and may initiate the immunostimulatory signaling 
through glial toll-like receptors (Luo et al., 2010). 
5. The role of retinal oxidative and nitrative injury in glaucomatous 
neurodegeneration 
5.1 Protein oxidation in glaucomatous neurodegeneration 
Protein carbonyl formation is a widely utilized marker for protein oxidation (Stadtman et 
al., 1991). The measurement of carbonyl groups is considered to be a good estimation for the 
extent of oxidative damage to proteins. Carbonyls, formed following reactive oxygen 
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species-mediated oxidation of sugar and membrane lipids, are able to form adducts 
commonly known as CO-proteins (proteins bearing carbonyl groups) with structural 
proteins, causing alterations in their biological activity (Shacter, 2000). Reactive carbonyl 
groups on proteins can also be formed by direct oxidation of protein side-chains (Reznick & 
Packer, 1994). Reactive oxygen species may oxidize amino acid residue side-chains into 
ketone or aldehyde derivatives. Histidine, arginine, and lysine are the most susceptible 
amino acids for reactive oxygen species-mediated protein carbonyl formation (Stadtman & 
Berlett, 1997). 
Most methods detecting protein-bound carbonyls are based on the covalent reaction of the 
carbonylated protein side chain with 2,4 dinitrophenyl-hydrazine and detection of 2,4-
dinitrophenylhydrazone groups with a specifıc anti-dinitrophenyl antibody. Protein-
hydrazone produced via the 2,4 dinitrophenyl-hydrazine reaction can also be quantified 
spectrophotometrically at an absorbance between 360-385 nm (Reznick & Packer, 1994). 
Serum protein carbonyl levels measured in 50 patients with pseudoexfoliation glaucoma 
and in 55 healthy controls revealed a significant increase in the diseased group (Yagci et al., 
2006). Protein carbonyl formation was also identified via proteomic analysis in a chronic 
pressure induced rat model of glaucoma (Tezel et al., 2005). In the reported study, 
carbonylated protein side chains present in control and ocular hypertensive retinal protein 
lysates were reacted with 2,4 dinitrophenyl-hydrazine and the formation of 2,4-
dinitrophenyl-hydrazone groups were identified with anti-dinitrophenyl antibody via two-
dimensional polyacrylamide gel electrophoresis. Approximately 60 protein spots, detected 
on 2D-oxyblots exhibited protein carbonyl immunoreactivity in ocular hypertension. Three 
of these proteins showed a significant increase in the relative percentage of carbonyl 
immunoreactivity as compared with controls. These spots were excised and in-gel digested 
prior to identification by matrix-assisted laser desorption ionization time-of flight mass 
spectrometry. Spectral masses obtained by matrix-assisted laser desorption ionization time-
of flight mass spectrometry were analyzed via bioinformatics through the Mascot and 
Profound search engines. Identified proteins through mass fingerprinting were 
glyceraldehyde-3-phosphate dehydrogenase, heat shock protein 72 and glutamine 
synthetase. 
Glyceraldehyde-3-phosphate dehydrogenase is a glycolytic enzyme, which catalysis the 
phosphorylation of glyceraldehyde-3-phosphate. The active site of this enzyme contains 
reactive SH-groups (Olsen et al., 1975), which can easily be oxidized in the presence of 
hydrogen peroxide (H2O2) or in the presence of systems producing superoxide (O2—) 
(Schmalhausen et al., 1999). Mild oxidation of glyceraldehyde-3-phosphate dehydrogenase 
results in the uncoupling of the oxidation and phosphorylation in glycolysis and decreases 
the content of ATP in the cell (Danshina et al., 2001). Thus, the oxidation of glyceraldehyde-
3-phosphate dehydrogenase leading to altered enzyme activity can play a key role in the 
development of different pathological processes including neuronal cell death associated 
with glaucoma. 
Posttranslational oxidative modification of heat shock protein 72 may have deleterious 
concequences on protein function. The primary function of heat shock protein 72 is to serve 
as an intracellular molecular chaperone of naive, aberrantly folded, or mutated proteins 
(Lindquist & Craig, 1988). Indeed, the expression of heat shock protein 72 in cultured rat 
retinal ganglion cells has been shown to increase tolerance to hypoxic and excitotoxic injury 
(Caprioli et al., 1996). Similarly, retinal ganglion cell protection was observed in a rat model 
of glaucoma treated with a heat shock protein inducer, geranylgeranylacetone (Caprioli et 
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al., 2003). Transient increase of Hsp expression in some regions of the brain has been 
reported following oxidative injury. Hsp70 is induced in injured neurons, while 
upregulation of Hsp27 occurs predominantly in glial cells following ischemic stress (Kalmar 
& Greensmith, 2009).  
Glutamine synthetase catalyzes the conversion of glutamate to glutamine and is a key 
enzyme participating in the metabolism of the major excitatory neurotransmitter, glutamate 
(Albrecht et al., 2007). Glutamine synthetase expression, also shown in retinal ganglion 
Müller cells (Linser et al., 1984), thus plays an important protective role against neuronal 
excitotoxicity. The effect of carbonyl formation on the function of glutamine synthetase 
remains to be elucidated but may have potential consequences on retinal ganglion cell death 
associated with glaucoma. 
5.2 Glyco-oxidation in glaucomatous neurodegeneration 
Advanced glycation end products form via non-enzymatic condensation reactions between 
reducing sugars and ε-amino groups or N-terminal groups. These glycation modifications 
occur preferentially on lysine and arginine amino acids, although they can occur on free 
amine containing lipids and DNA and proceed spontaneously via a complex series of 
chemical rearrangements to yield reactive products with varying crosslinking, pigmentation, 
and fluorescence properties (Brownlee et al., 1988). If oxidation accompanies glycation then 
the products formed are known as glyco-oxidation products (Fu et al., 1994). Advanced 
glycation end products are measured by spectroscopic and fluorimetric methods, exploiting 
their particular values of absorption (280 mn) and fluorescence (emission at 440 mn, 
excitation at 370 mn). However, these methods are not very specific and can only give 
indications on the general trend of the glycation process (Brownlee et al., 1988). More 
recently, radioimmunoassay and enzyme-linked immunosorbent assay methods have been 
developed, using polyclonal antibodies raised against advanced glycation end products and 
obtained in vitro from the glycation reaction of glucose with ribonuclease (Lapolla et al., 
2005). 
Although, nonenzymatic glycation of proteins is an important phenomenon in the 
development of vascular disease complications like macro- and microangiopathy (Bierhaus 
et al., 1998) it has also been recently observed in glaucoma (Tezel et al., 2007). Lens capsules 
of patients with Pseudoexfoliation syndrome and pseudoexfoliation glaucoma were 
immunostained to investigate the presence carboxymethylysine, a common glyco-oxidation 
product. In most of the obtained samples carboxymethylysine staining could be detected in 
epithelial cells of the lens capsules. However, direct correlation between clinical course and 
immunohistochemical reactivity could not be found (Zoric et al., 2006).  
The formation of advanced glycation end products leads to protein cross-linking and causes 
the destruction of cellular structures (Brownlee et al., 1988). Indeed, advanced glycation end 
products inhibitors such as aminoguanidine, has been reported to retard the development of 
vascular disease complications in animal models by preventing the formation of advanced 
glycation end products in various proteins including collagen (Yucel et al., 2006; Vasan et 
al., 2003).  
In a recent study, immunoperoxidase and double-immunoflıuorescence labeling were 
performed to determine advanced glycation end products and their receptor in the retina 
and optic nerve head obtained from donor eyes with glaucoma and age matched controls. 
Enhanced accumulation of advanced glycation end products and an up-regulation of 
receptor for advanced glycation end products were detectable in the glaucomatous retina 
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and optic nerve head compared with controls (Tezel et al., 2007). In the reported study, 
cellular localization of advanced glycation end products and receptor for advanced 
glycation end products were determined via double immunolabeling with antibodies 
against glial fibrillary acidic protein, antivimentin and brn-3, markers of astrocytes, Müller 
cells, and retinal ganglion cells, respectively. Increased advanced glycation end products 
immunolabeling in glaucoma was mainly observed in the extracellular compartment and 
included laminar cribriform plates in the optic nerve head, while immunolocalization of 
receptors for advanced glycation end products was predominantly associated with 
astrocytes (Tezel et al., 2007). 
5.3 Lipid peroxidation in glaucomatous neurodegeneration 
Reactive oxygen species, generated during oxidative stress can induce peroxidation of lipids 
(either cellular membrane lipids or circulating lipoprotein molecules) and generate highly 
reactive aldehydes (Spiteller, 2006). The resultant end products, malondialdehyde or 4-
hydroxynonenal are well-known markers in the pathologic molecular process in oxidative 
stress (Poli & Schaur, 2000). 4-hydroxynonenal derives from ω-6 polyunsaturated fatty acids 
like linoleic and arachidonic acid, whose conjugated double bonds are an easy target for 
species that can extract a hydrogen atom or add to a double bond (Poli et al., 2004). 
Although lipid peroxidation has been quantitatively assessed by measuring 
malondialdehyde levels by the thiobarbituric acid-reacting substances assay, Thiobarbituric 
acid-reacting substances is considered to be a nonspecific marker of membrane lipid 
peroxidation, likely due to reaction of thiobarbituric acid with non-lipid moities (Yeo et al., 
1994). Free radical-induced oxidation of arachidonic acid (20:4ω6), an unsaturated 20 carbon 
fatty acid released from membrane phospholipids, results in formation of F2- and D2/E2-
isoprostanes (IP) (Pratico, 1999). Recent studies indicate that measurement of IP provides a 
reliable noninvasive approach to assess lipid peroxidation in vivo (Morrow, 2000).  
A number of DNA adducts arising from lipid hydroperoxide-derived products have been 
identified by liquid chromatography-mass spectrometry (Blair, 2008). Malondialdehyde is 
one of the most studied lipid hydroperoxide-derived product that causes DNA damage 
(Marnett et al., 2003). However, the cyclic DNA-adduct it forms with dGuo (M1dG) is not a 
specific marker of lipid hydroperoxide-mediated DNA-adduct formation. M1dG may be a 
useful biomarker of endogenous DNA damage resulting from oxidative stress (Blair, 2008). 
Lipid hydroperoxide-DNA adducts, which are repaired and appear in the urine, can be used 
as surrogate biomarkers of DNA damage. Urinary heptanone-etheno (Hε) dAdo (HεdAdo), 
HεdGuo, and HεdCyd, which are formed exclusively by lipid hydroperoxide-mediated 
DNA damage, can be useful urinary biomarkers (Blair, 2008). Heptanone-etheno dCyd is 
highly mutagenic in cells (Pollack et al., 2006) and thus its quantification in the urine may 
have a clinical relevance. 
UV spectrophotometry and fluorescent analysis were used to study the accumulation of 
conjugated dienes, end products of lipid peroxidation, in lipid extracts from lenses, aqueous 
humour and trabecular tissues, obtained from 49 eyes of patients with primary open angle 
glaucoma. Lipid peroxidation products have been found in significantly higher concentrations 
in the aqueous humour and trabecular tissue of glaucoma patients compared with control 
subjects (Babizhayev & Bunin, 1989). Similarly, a 2.5-fold increase in malondialdehyde levels 
were observed in lens capsule samples of patients with pseudoexfoliation syndrome when 
compared with normal age-matched control subjects (Gartaganis et al., 2007). Likewise, the 
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mean concentration of 8-isoprostaglandin F2 measured in the aqueous fluid from patients 
with Pseudoexfoliation syndrome was significantly higher than those of age-matched 
control patients (Koliakos et al., 2003). 
Increased vitreous and retina malondialdehyde levels were also detected in rats with 
elevated intraocular pressure (Yucel et al., 2005). As mentioned previously, peroxidation of 
polyunsaturated fatty acids results in the formation of multiple aldehydes including 4-
hydroxynonenal, which is capable of inducing apoptosis in neuronal cells (Kruman et al., 
1997). The dose and time dependent effects of 4-hydroxynonenal were studied on primary 
cultures of human optic nerve head astrocytes, generated from normal and glaucomatous 
human eyes (Malone & Hernandez, 2007). Treatment with 4-hydroxynonenal at 
concentrations of 50 mM and higher led to a greater than 50% reduction in cell viability of 
normal optic nerve head astrocytes over 6 h (Malone & Hernandez, 2007). 
Glutathione is the most abundant non protein thiol in the cell and a key cellular antioxidant 
important in the inactivation of 4-hydroxynonenal (Dickinso et al., 2004). A significant 
depletion of glutathione levels was observed in normal astrocytes after exposure to 4-
hydroxynonenal for over an hour (Kruman et al., 1997). Basal levels of glutathione in 
primary cultures of human optic nerve head astrocytes from glaucomatous eyes were 
reported to be below the level of detection compared with primary cultures from normal 
astrocytes (Malone & Hernandez, 2007). This finding suggests the presence of an altered 
antioxidant defence mechanism in glaucoma. A significant increase in glutathione levels 
were measured in both normal and glaucomatous astrocytes 24 h after 4-hydroxynonenal 
removal (Malone & Hernandez, 2007). 
Human optic nerve head astrocytes treated with 25 μM 4-hydroxynonenal for over an hour 
induced expression of glutamate cysteine ligase catalytic subunit (Malone & Hernandez, 
2007), leading to an increase in glutathione synthesis thereby enhancing cellular oxidant 
defense mechanisms (Dickinson et al., 2002). Expression of aldoketo reductase 1C, which 
metabolizes 4-hydroxynonenal to an inactive metabolite, was also elevated in optic nerve 
head astrocytes treated with 25 μM 4-hydroxynonenal for over an hour (Malone & 
Hernandez, 2007). The expression of glutathione S-transferase, which catalyzes the 
conjugation of 4-hydroxynonenal to glutathione, was similarly induced in optic nerve head 
astrocytes via 4-hydroxynonenal incubation (Malone & Hernandez, 2007). Induction of the 
aforementioned enzymes confers a protection mechanism against oxidative damage in optic 
nerve head neuronal cells in humans. 
Increased lipid peroxidation accompanied by altered antioxidant enzyme activities was also 
observed in rats with glaucoma induced by 6 week injection of hyaluronic acid into the 
anterior chamber (Moreno et al., 2004). Retina lipid peroxidation, measured as thiobarbituric 
acid-reacting substances significantly increased in a time and hypertension dependent 
manner. The observed increase in thiobarbituric acid-reacting substances was accompanied 
by a decrease in glutathione, catalase and superoxide dismutase enzyme activities 
suggestive of an altered antioxidant defense mechanism (Moreno et al., 2004). 
5.4 Protein nitration in glaucomatous neurodegeneration 
Aromatic nitration is recognized to be a mediator of pathological conditions and signaling 
events encompassing nitric oxide (NO) and oxidative stress. Numerous in vitro biochemical 
studies have demonstrated that nitration of protein tyrosine residues can alter protein 
function (Cassina et al., 2000). It has been shown that 3-nitrotyrosine (NO2Tyr),  
3-bromotyrosine and 3-chlorotyrosine, selective markers of protein nitration (MacPherson et 
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al., 2001). Indeed, the detection of protein NO2Tyr is commonly used as a diagnostic marker 
of nitric oxide (NO).-derived oxidants in both human disease states and animal models 
(Aslan et al., 2003). Various techniques including western blotting, enzyme-linked 
immunosorbent assay, immunochemistry, HPLC and mass spectrometry are employed to 
determine the formation of NO2Tyr in a variety of disease states (Aslan et al., 2003). 
Elevated intraocular pressure augments nitric oxide synthase-2 expression, retinal protein 
nitration and apoptosis (Aslan et al., 2006) and suggests that protein nitration and apoptosis 
exacerbate disease progression in clinical conditions accompanied by ocular degeneration. 
Thus, selective inhibiton of nitric oxide synthase-2 and appropriate intraocular pressure-
lowering may prevent long-term visual loss and lead to improvement in the management of 
glaucoma. Indeed, pharmacological studies have shown that inhibition of nitric oxide 
synthases-2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat 
model of chronic glaucoma (Neufeld et al., 1999). Nitric oxide synthase-2 immunostaining 
observed in glaucomatous optic nerve head suggests that it may contribute to retinal 
ganglion cell death associated with elevated intraocular pressure (Liu & Neufeld, 2000; 
Shareef et al., 1999). 
5.5 DNA oxidation in glaucomatous neurodegeneration  
Oxidative DNA damage can lead to DNA-protein cross linking, strand breaks and base 
modifications. Oxidative DNA damage is assessed by measuring levels of 8-hydroxy-2′-
deoxyguanosine (8-OH-dG), an indicator of oxidative DNA damage (Dizdaroglu, 1992).  
8-hydroxy-2′-deoxyguanosine (8-OH-dG) can be measured by high pressure liquid 
chromatography with electrochemical detection or by gas chromatography/mass 
spectrometry, a technique that combines gas-liquid chromatography and mass spectrometry 
to identify different substances within a test sample (Shigenaga et al., 1994). DNA strand 
breaks can be detected in tissues and cells via alkaline elution assay or terminal 
deoxynucleotide transferase-mediated in situ end-labeling, respectively (Collins & 
Horvathova, 2001). 
Elevated intraocular pressure due to reduction in aqueous outflow facility is a major causal 
effect in glaucoma (Yan et al., 1994). The eye's outflow system consists of a series of 
endothelial cell–lined structures in the angle of the anterior chamber, which also include the 
trabecular meshwork. Levels of 8-hydroxy-2′-deoxyguanosine (8-OH-dG), a marker of 
oxidative DNA damage, was determined in human trabecular meshwork specimens 
collected from patients with primary open angle glaucoma (Sacca et al., 2005). The 
relationship between DNA oxidation, intraocular pressure and visual field damage and 
disease duration were also evaluated. Eight-hydroxy-2′-deoxyguanosine (8-OH-dG) was 
measured in extracted DNA samples by using a 32P-postlabeling procedure (Sacca et al., 
2005). A statistically significant correlation was also found among oxidative DNA levels, 
visual field damage and intraocular pressure. It was concluded that oxidative DNA damage 
may induce human trabecular meshwork degeneration, leading to increased intraocular 
pressure.  
Glutathione S-transferases are ubiquitous multifunctional enzymes, which play a key role in 
cellular detoxification. These enzymes protect cells against toxicants by conjugating them to 
glutathione, thereby neutralizing their electrophilic sites and increasing the products water-
solubility (Mannervik et al., 1985). Glutathione S-transferase M1 gene polymorphism was 
examined in human trabecular meshwork specimens collected from 45 primary open angle 
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glaucoma patients undergoing therapeutical eye surgery (trabeculectomy) and unaffected 
controls (Izzotti, 2003). An association was found between Mu-class glutathione  
S-transferase null allele and primary open angle glaucoma, suggesting a possible genetic 
predisposition of defective Mu-class glutathione S-transferase null allele in the disease. 
Primary open angle glaucoma patients having Mu-class glutathione S-transferase null allele 
deletion had 2.2-fold higher 8-hydroxy-2′-deoxyguanosine (8-OH-dG) amounts than Mu-
class glutathione S-transferase null allele positive subjects. In addition, Mu-class glutathione 
S-transferase null allele deletion was significantly more frequent in primary open angle 
glaucoma patients than in unaffected controls. 8-hydroxy-2′-deoxyguanosine (8-OH-dG) 
was increased (3.6-fold) in primary open angle glaucoma patients as compared with 
controls. Preliminary results from this study indicate that glutathione S-transferase genes 
are expressed in human trabecular meshwork under physiological conditions and that 
oxidative DNA damage is associated with primary open angle glaucoma. 
6. Potential applications of antioxidants in glaucomatous neurodegeneration 
As presented herein, chronic oxidative stress is involved in glaucoma pathogenesis, most 
notably, its age-dependent clinical onset. Ocular tissues and fluids contain antioxidants that 
play a key role in protecting against oxidative damage. Superoxide (O2—) is removed either 
by cytoplasmic, mitochondrial or extracellular superoxide dismutases, which dismutate 
superoxide (O2—) to yield hydrogen peroxide (H2O2) and oxygen (O2) (Fridovich, 1986). 
Hydrogen peroxide formed in the anterior segment tissues of the eye is removed by the 
heme-containing enzyme catalase or by glutathione peroxidase (Costarides et al., 1991). The 
specific activity of superoxide dismutase and catalase can be measured in both normal fresh 
human cadaver trabecular meshwork (De La Paz & Epstein, 1996) and in the iris and corneal 
endothelium of rabbits (Riley, 1990). Specific activity of superoxide dismutase, but not 
catalase, demonstrates an age-dependent decline in normal cadaver human trabecular 
meshwork. However, age-dependent decline of catalase activity is only observed in the iris 
and corneal endothelium of rabbits. 
A decrease in serum superoxide dismutase and catalase activity was also observed in 
patients with Pseudoexfoliation syndrome compared with age-matched controls (Zoric  
et al., 2006). Glutathione and oxidized glutathione levels were also decreased in 
pseudoexfoliation lens epithelial cells compared with non- pseudoexfoliation controls 
(Gartaganis et al., 2007). Furthermore, mean ascorbic acid concentration in the aqueous 
humour of patients pseudoexfoliation syndrome was significantly lower than that found in 
control patients (Koliakos et al., 2003).  
Glutathione and ascorbic acid (Vitamin C) are low molecular weight antioxidants that can 
be detected in the aqueous humor of humans (Richer & Rose, 1998). Rapid loss of Vitamin E 
during lipid peroxidation can be diminished by ascorbic acid, which is known to recycle the 
Vitamin E radical (May, 1999). No significant difference was found in blood levels of 
ascorbic acid measured in 38 patients with chronic open-angle glaucoma and 12 controls 
(Asregadoo, 1979). On the contrary, plasma glutathione levels assessed in 21 patients with 
newly diagnosed primary open angle glaucoma and 34 age- and gender-matched control 
subjects revealed that glaucoma patients exhibited significantly lower levels of reduced and 
total glutathione than did control subjects (Gherghel et al., 2005). 
Lutein and zeaxanthin are oxygenated carotenoids that form the macular pigment. Of the 10 
carotenoids that have been reported in the human serum, only two, zeaxanthin and lutein 
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are found in the human retina (Roberts et al., 2009). Although it is suggested that zeaxanthin 
and lutein are concentrated in the retina because of their ability to cross the blood brain 
barrier of the retinal pigment epithelium and scavenge free radicals (Roberts et al., 2009), no 
strong association was found between dietary intake of lutein and zeaxanthin and the risk 
for glaucoma (Rhone & Basu, 2008). Conversely, a recent study showed that treatment with 
astaxanthin, a naturally occurring carotenoid pigment and a powerful biological 
antioxidant, reduced oxidant-induced protein oxidation, lipid peroxidation and apoptotic 
cell death in experimental rat models of elevated intraocular pressure (Cort et al., 2010).  
Polyphenolic flavonoids (tea, coffee, wine, dark chocolate and ginkgo bilboa), alpha lipoic 
acid, coenzyme Q10 and melatonin are natural substances with antioxidant activity in 
glaucomatous neurodegeneration (Mozaffarieh et al., 2008a). 
The effects of resveratrol, which is a naturally occurring polyphenol found in berries, nuts, 
and red wine was studied in primary porcine trabecular meshwork cells subjected to 
chronic oxidative stress (Luna et al., 2009a). Primary porcine trabecular meshwork cells 
were submitted to chronic treatment with resveratrol or vehicle every three days for 15 
days. Cells under resveratrol or vehicle treatment were incubated under oxidative stress 
conditions (40% oxygen) and control cultures were treated with vehicle and incubated at 
physiological oxygen concentration (5%). The level of endogenous reactive oxygen species 
was significantly decreased by resveratrol treatment (4 fold) compared with cells treated 
with vehicle. The amount of intracellular reactive oxygen species in resveratrol-treated cells 
under oxidative stress was similar to that of non-stressed control cells. The induction of 
mRNA expression of the inflammatory markers interleukin-1ǂ, -6, -8 and endothelial-
leukocyte adhesion molecule after chronic oxidative stress was significantly inhibited by 
chronic treatment with resveratrol. The accumulation of carbonylated proteins induced by 
oxidative stress was significantly lower in resveratrol-treated samples compared with 
samples treated with vehicle under oxidative stress. Resveratrol-treated cells showed 
protection against apoptosis after acute oxidative stress (200, 400, and 800 µM of hydrogen 
peroxide [H2O2]), when compared with cells treated with vehicle. Vehicle-treated cells 
showed a linear correlation between hydrogen peroxide (H2O2) concentration and 
apoptosis; cells treated with resveratrol exhibited protection against apoptosis in all 
hydrogen peroxide (H2O2) concentrations. Resveratrol treatment did not result in significant 
changes in proliferation and in the amount of DNA damage when compared with cells 
treated with vehicle. The data suggests that resveratrol could potentially have a role in 
preventing the trabecular meshwork tissue abnormalities observed in primary open angle 
glaucoma (Luna et al., 2009). 
The antioxidative properties of ginkgo are due to its direct radical scavenging activity. 
Ginkgo biloba prevents oxidative damage to mitochondria, exhibits neuroprotective 
properties, inhibits LDL oxidation, has a relaxing effect on vascular walls, and an 
antagonistic action on platelet activating factor (Mozaffarieh et al., 2008a). Administration of 
ginkgo increases ocular blood flow velocity in patients (Chung et al., 1999), and improves 
visual field in normal tension glaucoma patients (Quaranta at al., 2003). The beneficial 
properties of ginko biloba suggest it to be of major therapeutic value in the treatment of 
glaucoma (Ritch, 2000). 
The water and fat soluble vitamin alpha lipoic acid is found in foods such as red meat, liver, 
and yeast. Alpha lipoic acid is capable of regenerating several other antioxidants back to 
their active states, including vitamin C, vitamin E, glutathione and coenzyme Q10 
(Mozaffarieh et al., 2008a).  
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Coenzyme Q10 is a coenzyme for the inner mitochondrial enzyme complexes involved in 
energy production within the cell (Choi et al., 2005). Coenzyme Q10 has been demonstrated 
to prevent lipid peroxidation and DNA damage induced by oxidative stress (Tomasetti et 
al., 2001). Oral administration of ubiquinone was shown to be useful in mitigating 
cardiovascular side-effects without affecting intraocular pressure in glaucoma patients 
(Takahashi et al., 1989). 
Melatonin reduces the elevation of cGMP by suppressing nitric oxide synthase activity, 
indicating a neuroprotective role in the retina (Mozaffarieh et al., 2008a; Sa’enz et al., 2002). 
Findings indicate that melatonin reduces nitric oxide (NO)-induced retinal oxidative 
damage both in vitro and in vivo. Furthermore, several of the metabolites that are generated 
when melatonin inactivates toxic reactants are themselves free radical scavengers 
(Mozaffarieh et al., 2008a). In addition, melatonin stimulates a number of antioxidative 
enzymes, which further promote antioxidative protection (Rodriguez et al., 2004). 
The role of dorzolamide, which is a topical carbonic anhydrase inhibitor that plays 
significant intraocular pressure-lowering activity and vasoactive effect, was studied on the 
oxidative/antioxidant status of aqueous humor in patients with primary open angle 
glaucoma (Zanon-Moreno et al., 2009). One hundred thirty patients were divided into three 
groups; patients with primary open angle glaucoma without dorzolamide administration 
(n=34); patients with primary open angle glaucoma with dorzolamide administration 
(n=36); and subjects with cataract (comparative group, n=60). Oxidative activity was 
measured in the aqueous humor by malondialdehyde determination by thiobarbituric acid-
reacting substances assay. Antioxidant status was assessed in the aqueous humor samples 
by measuring the superoxide dismutase activity and the total antioxidant status. Oxidative 
activity was significantly higher in both glaucoma groups than in the cataract group and 
was significantly higher in subjects without dorzolamide administration. Superoxide 
dismutase activity was significantly higher in both glaucoma groups than in the cataract 
group, and was significantly higher in glaucoma without dorzolamide administration than 
in glaucoma with dorzolamide treatment. Total antioxidant status was significantly 
decreased in both glaucoma groups compared with the cataract group, and was more 
significantly decreased in glaucoma without dorzolamide administration than in glaucoma 
with dorzolamide administration (Zanon-moreno et al., 2009). The data suggest that topical 
administration of dorzolamide diminishes oxidative stress in patients with glaucoma. 
The protective effects of prostaglandin analogues (bimatoprost, travoprost, and latanoprost) 
on oxidative stress–induced trabecular meshwork changes in primary open angle glaucoma 
was studied in primary cell cultures of human trabecular meshwork and furthermore 
whether these protective effects of prostaglandin analogues could be blocked by 
pretreatment with prostaglandin F receptor antagonists was investigated (Yu et al., 2008). 
The cells were exposed to hydrogen peroxide (H2O2) for 1 hour. The effects of prostaglandin 
analogues and benzalkonium chloride, which is the most widely used preservative in 
commercially available eye drops, on trabecular meshwork were investigated by 
preincubation of nonstressed or hydrogen peroxide (H2O2)-treated cells with 1:100 diluted 
commercial solutions of bimatoprost, travoprost, and latanoprost or their corresponding 
BAC concentrations. Pretreatment with BAC further increased the typical glaucomatous 
trabecular meshwork changes, which were characterized by cell loss, increased 
accumulation of extracellular matrix and cellular senescence in vitro. These effects were 
reduced by preincubation with prostaglandin analogues in hydrogen peroxide (H2O2)-
treated and non-stressed cells. There was no reduction in the presence of prostaglandin F 
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receptor antagonists in hydrogen peroxide (H2O2)-treated cells. These data suggest that 
oxidative stress–induced trabecular meshwork changes can be minimized by the use of 
prostaglandin analogues and prevention of oxidative stress exposure to the trabecular 
meshwork may help to reduce the progression of primary open angle glaucoma. 
A refined monosodium luminal, Galavit, has antioxidant and antiinflammatory effects in 
human (Butorov et al., 2005) and glaucomatous mice (Jiang et al., 2006). The 
immunohistochemical distribution of glutathione, glutamine synthetase, and glutamate was 
examined in normal C57BL/6 mice (negative control), glaucomatous DBA2J mice (positive 
control), and glaucomatous DBA/2J mice treated with Galavit (Gionfriddo et al., 2009). 
Serial sections were immunogold stained for glutamate, glutamine synthetase and total 
glutathione, followed by image analysis for staining patterns and density. Focal decreases in 
glutamate immunostaining were common in the inner nuclear layer of glaucomatous 
DBA/2J retinas, but not in C57BL/6 or Galavit-treated glaucomatous DBA/2J retinas. 
Decreases in glutathione and glutamine synthetase immunostaining were found in 
glaucomatous DBA/2J retinal regions where neuronal glutamate immunostaining was 
reduced. Retinas from Galavit-treated glaucomatous DBA/2J had no significant decreases in 
inner nuclear layer levels of glutamate, glutathione, or glutamine synthetase. The data 
suggest that the antioxidant Galavit may prove to be effective in delaying or preventing 
retinal dysfunction and damage in at least some types of glaucoma. 
7. Conclusions 
Oxidative and nitrative processes have an important role in the pathogenesis of 
glaucomatous neurodegeneration (figure 5).  
 
 
Fig. 5. Scheme of retinal oxidative damage 
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Despite all documentation of experimental data there is still limited understanding to 
whether free radical generation is a primary or a secondary event in glaucomatous 
neurodegeneration. As discussed herein, oxidative damage in the cellular components of the 
trabecular meshwork could directly affect the regulation of the extracellular matrix structure 
and lead to an alteration in the flow of the aqueous humor. Perturbation of the eye's outflow 
will thus cause an elevation in intraocular pressure, leading to clinical onset of glaucoma. In 
such set of circumstances, oxidative stress can be considered as a secondary event in the 
pathogenesis of glaucoma. Retinal oxidative injury occurring in models of elevated 
intraocular pressure or in normal tension glaucoma could also directly damage the retinal 
ganglion cell layer, leading to glaucomatous optic neuropathy. Continued trials of 
therapeutic interventions to reduce in vivo oxidative stress seem relevant in patients with the 
disease. Probably, an effective mode of protective therapy would be to start the therapeutic 
interventions at an early stage of the disease and target specific sites of reactive species 
generation. It is desirable that future studies and clinical trails will further advance our 
understanding on mechanisms of neuronal degeneration in glaucoma and help in the design 
of more effective therapies. 
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